Applied Therapeutics (APLT)
(Delayed Data from NSDQ)
$0.45 USD
+0.03 (8.24%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $0.44 -0.01 (-1.17%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Applied Therapeutics Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
APLT 0.45 +0.03(8.24%)
Will APLT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for APLT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for APLT
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q1 Loss, Lags Revenue Estimates
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Misses Revenue Estimates
APLT: What are Zacks experts saying now?
Zacks Private Portfolio Services
BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?
Company News for Dec 2, 2024
Biotech Stock Roundup: BBIO Stock Up on Drug Approval, SAVA, APLT Plunge on Setbacks & More
Other News for APLT
Is APLT building bearish momentum? 180 Bearish Setup shows up after slipping 4.35%
Is APLT preparing to trend higher? Bullish Engulfing shows up after gaining 3.37%
APLT forms Lower Bollinger Band Walk on September 15
APLT falls 4.71% on September 12, leaving the technical picture intact
Is APLT primed for upward momentum? Stochastic Buy Signal shows up after slipping 0.7%